These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 17193252)

  • 1. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
    Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
    Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
    Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
    J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium.
    Jo YS; Huong DT; Bae K; Lee MK; Kim YH
    Planta Med; 2002 Jan; 68(1):84-5. PubMed ID: 11842339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
    J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
    Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
    Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Viña D
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4224-7. PubMed ID: 21684743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
    Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
    Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of species-dependent differences on screening, design, and development of MAO B inhibitors.
    Novaroli L; Daina A; Favre E; Bravo J; Carotti A; Leonetti F; Catto M; Carrupt PA; Reist M
    J Med Chem; 2006 Oct; 49(21):6264-72. PubMed ID: 17034132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study.
    Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3697-703. PubMed ID: 15203146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
    Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
    ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkynyl-coumarinyl ethers as MAO-B inhibitors.
    Mertens MD; Hinz S; Müller CE; Gütschow M
    Bioorg Med Chem; 2014 Mar; 22(6):1916-28. PubMed ID: 24560738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships.
    Altomare C; Cellamare S; Summo L; Catto M; Carotti A; Thull U; Carrupt PA; Testa B; Stoeckli-Evans H
    J Med Chem; 1998 Sep; 41(20):3812-20. PubMed ID: 9748356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
    Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.